Patrick J. Flynn, MD, will be
honored with the Association of Community Cancer Centers'
(ACCC) David King Community Clinical Scientist Award for his
outstanding service, leadership, and commitment to the oncology
Flynn is medical
director, Autologous Bone Marrow and Stem Cell Transplant at
Cancer Institute - Abbott Northwestern Hospital, part of
Minnesota Oncology Hematology,
PA. He is also adjunct associate professor of medicine at
the University of Minnesota Medical School, and principal
investigator at the Metro-Minnesota CCOP.
The award will be presented at the ACCC 39th Annual National
Meeting on Friday, March 8, 2013, in Washington, D.C.
Under Dr. Flynn's leadership, clinical trial accrual has
risen from 50 to 500 patients per year, achieving success
through a consortium of physicians, clinics, and hospitals
that cover the entire metropolitan Twin Cities and beyond.
"My goal has been to take the research to where people live
rather than expect people to travel to the research," he
said. "I plan to continue my efforts to promote cooperative
research by playing a direct role at the national groups."
His areas of interest include autologous peripheral blood
stem cell transplantation; hematology, including bleeding and
clotting disorders; and colorectal cancer.
David King Community Clinical Scientist Award winners become
lifetime members of the ACCC National Academy of Community
Oncology Scientists, which will serve as a valuable resource
to ACCC, NCI, pharmaceutical companies, and other
organizations involved in community cancer research.